Release Date: 21/09/23 08:55 Summary: SEMI Annual Financial Report Price Sensitive: No Download Document 524.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%